The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

NCT05146843 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Mitoquinone
OTHER: Placebo

Sponsor

D'Or Institute for Research and Education

Collaborators

[object Object]
[object Object]